Gara Jalqabaatti › Dukkana Cell Dendritic Plasmacytoid Blastic
Qorannoo klinikaalii Dukkana Cell Dendritic Plasmacytoid Blastic Ameerikaa Keessatti hirmaatuu
Qorannoo 8 Dukkana Cell Dendritic Plasmacytoid Blastic f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
Naannoon
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT04216524Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Namoota walitti qabaa jiraSadarkaa 2
6 Months – 65 Years · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06013423SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT03113643Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 05-Wax-2026 · NCT05430971CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 21 · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT04318678HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 80 · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT03326921Q702 for the Treatment of Patients With Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Onk-2025 · NCT06712810Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.